This highly anticipated psychedelic docuseries showcases what these substances teaches people about consciousness, dying, addiction, depression and transcendence. Filmmaker Alex Gibney and best-selling author Michael Pollan present it in four parts, each focused on a different mind-altering substance: LSD, psilocybin, MDMA, and mescaline. With Pollan as our guide, we journey to the frontiers of the new psychedelic renaissance -- and look back at almost-forgotten historical context -- to explore the potential of these substances to heal and change minds as well as culture. The first chapter is a great introduction to the topic of LSD, from its 1943 origins to today's microdosing trend, for those who don’t already know a lot about the subject, and a fun and entertaining refresher on LSD for even experts in the field. The show takes us on a journey through the history of the powerful compound, from its discovery and its early medical use, to secret CIA mind-control studies, the counterculture and its banning, and finally to our current renaissance. It includes amazing clips of LSD’s inventor Albert Hofmann and powerful personal testimonies of individuals who have healed their suffering through LSD.
The Last Shaman
James is an all American boy whose promising life is brought to a halt by acute depression. Turning his back on the most progressive western treatments and medicines, James discovers ayahuasca in search of healing in the Peruvian jungle. Over the course of 10 months venturing from Shaman to Shaman, James finds friendship, answers and a kind of redemption hidden deep in the Peruvian amazon. (Click CC for subtitles)
A ground-breaking new trial at Imperial College London sees, for the first time ever under controlled conditions, a psychedelic drug tested head-to-head against a standard antidepressant as a treatment for depression. The film follows a pioneering team of scientists and psychotherapists as they compare the effects of psilocybin (the active ingredient of magic mushrooms) with an antidepressant on a small group of participants with clinical depression. This is scientific research at its most cutting edge. With over seven million people being prescribed antidepressants each year in England alone, this drug trial is an important milestone in understanding a completely different treatment for depression. How do psychedelic drugs measure up against the industry-standard antidepressants that have been popular since the 1990s? The empirical results of the trial are explored alongside the participants’ powerful lived experience.
Modern headlines are claiming mindfulness may cure anxiety, depression, and a whole host of other health problems. How can this simple practice of watching your own breath change the way your brain works? And can that change your life? The fourth episode of the series looks at the power of mindfulness and meditation. It examines different kinds on meditation (transcendental, dynamic, and religious) and notes that they are different from mindfulness meditation (Satipatthana). Also it talks to neuroscientists who discuss what happens in the brain during meditation.
Mixing comedy with a thorough investigation of psychedelics, the film explores the pros, cons, science, history, future, pop cultural impact, and cosmic possibilities of hallucinogens. The documentary features comedic tripping stories from A-list actors, comedians, and musicians. Star-studded reenactments and trippy animations bring their surreal hallucinations to life. 'Have a Good Trip' tackles the big questions: Can psychedelics have a powerful role in treating depression, addiction, and helping us confront our own mortality? Are we all made of the same stuff? Is love really all we need? Can trees talk?
the rise and fall of a tech industry prodigy. Interviews with his friends and loved ones paint a portrait of Swartz as a martyr of freedom of information and hail his fight for the public's right to access tax-funded academic and scientific research, culminating in a personally devastating two-year Federal lawsuit." An avid researcher who had previously accessed otherwise private databases, Swartz, acting "in the grand tradition of civil disobedience to declare... opposition to this private theft of public culture" used MIT computers to access tax-funded research that would otherwise be held privately by for-profit publishers, an incident many viewers may remember from national headlines just a few year ago. Though neither MIT nor the digital repository Swartz accessed pressed charges, a US Attorney stepped in and filed a 13-count felony charge against Swartz, threatening him with over $1 million in fines and up to 35 years of jail time. Despite the defense of his peers, these events launched Swartz into a two-year long downward spiral of withdrawal and depression. Aaron Swartz's untimely death at the age of 26.
The first chapter is a great introduction to the topic of LSD, from its 1943 origins to today's microdosing trend, for those who don’t already know a lot about the subject, and a fun and entertaining refresher on LSD for even experts in the field. The show takes us on a journey through the history of the powerful compound, from its discovery and its early medical use, to secret CIA mind-control studies, the counterculture and its banning, and finally to our current renaissance. It includes amazing clips of LSD’s inventor Albert Hofmann and powerful personal testimonies of individuals who have healed their suffering through LSD.